Severino Antinori is professor of reproductive physiopathology at the Medical Faculty of the Tor Vergata University in Rome. He is also scientific director of the International Research Association for Human Reproduction. He was formerly professor of physiopathology of reproduction at the University of Pisa. He is president of the Italian Society for Reproductive Medicine and vice-president of the International Association of Assisted Reproductive Medicine Centers and Laboratories. He has published more than 180 papers, mainly on male sterility, menopausal pregnancies, and human reproduction. He has published in The Lancet and The Journal of Assisted Genetics.

Brigitte Boisselier is the director of Clonaid, the first human-cloning company. She received a PhD in physical chemistry from the University of Dijon, France, in 1982 and another in analytic chemistry from the University of Houston in 1985. She has published extensively in Inorganic Chemistry and Analytic Chemistry, and she holds three patents for chemical processes. Dr. Boisselier’s primary focus has been on the analysis of porphyrins with various metal-carbon and metal-metal bonds. She continues to carry on research stemming from her dissertation, which focused on porphyrins and the influence of axial and equatorial ligands on reduction-oxidation characteristics. A strong advocate of undergraduate research and scholarship, Dr. Boisselier wrote Science et Conscience, a book for the general public on advances in science.

R. Alta Charo is professor of law and bioethics at the University of Wisconsin (UW) Law and Medical Schools, where she teaches bioethics and biotechnology law, food and drug law, reproductive rights, torts, and legislative drafting. In addition, she has served on the UW Hospital clinical ethics committee, the UW Institutional Review Board for the protection of human subjects in medical research, and the UW Bioethics Advisory Committee. Before her arrival at UW in 1989, Professor Charo served as associate director of the Legislative Drafting Research Fund of Columbia University, Fulbright Junior Lecturer in American Law at the Sorbonne in Paris, legal analyst for the Biological Applications Program of the congressional Office of Technology Assessment, American Association for the Advancement of Science, and Diplomacy Fellow for the Policy Development Division of the Office of Population at the US Agency for International Development. She was a member of the 1993 National Institutes of Health Human Embryo Research Panel and since 1996 has been a member of the presidential National Bioethics Advisory Commission.